Behnaz Eftekhari | Vascular Graft | Innovative Research Award

Published on by Cardiology and Cardiovascular Medicine

Innovative Research Award

Behnaz Eftekhari
Scripps Health

Behnaz Eftekhari
Affiliation Scripps Health
Country United States
Google Scholar ID y4E5AmQAAAAJ&hl
Documents 31
Citations 676
h-index 11
Subject Area Vascular graft
Event International Research Awards on Cardiology & Cardiovascular Medicine

Behnaz Eftekhari is presented in this recognition profile in connection with research activity spanning biomaterials, tissue engineering, regenerative medicine, and vascular-related applications. Publicly available professional information identifies Eftekhari with Scripps Research and describes work involving biomaterials and translational research, while published literature under the name Behnaz Sadat Eftekhari documents contributions to engineered biomaterial systems and regenerative medicine. [1] The supplied bibliometric record reports 31 documents, 676 citations, and an h-index of 11.

Abstract

Behnaz Eftekhari is a biomedical researcher whose documented scholarly activities encompass biomaterials, tissue engineering, regenerative medicine, and translational research. Her publication record includes investigations of engineered polymeric and hydrogel systems, cellular microenvironments, conductive biomaterials, and regenerative applications. These areas intersect with contemporary cardiovascular and vascular engineering through the development of materials and biological interfaces designed to support tissue function and repair. Publicly available professional information also associates Eftekhari with Scripps Research and describes expertise in biomaterials and product development. [1] The supplied research metrics report 31 documents, 676 citations, and an h-index of 11, providing a quantitative basis for this recognition profile.

Keywords

Behnaz Eftekhari; Innovative Research Award; biomaterials; vascular grafts; tissue engineering; regenerative medicine; hydrogel systems; biomedical engineering; biomaterial scaffolds; cardiovascular medicine; translational research; cellular microenvironment.

Introduction

Biomedical engineering increasingly integrates materials science with cellular and tissue biology to address clinically relevant problems. Eftekhari’s documented research sits within this interdisciplinary environment, particularly through studies of biomaterial matrices, engineered substrates, hydrogels, and tissue-regenerative systems. Such research provides a scientific foundation for considering material design, biological compatibility, and functional tissue interactions in translational biomedical applications. [2]

Research Profile

Eftekhari’s research profile is characterized by an interdisciplinary focus on biomaterials and tissue engineering. Publicly indexed publications under the name Behnaz Sadat Eftekhari include studies of chitosan-based conductive hydrogels, polymeric nanoparticles, mesenchymal stem-cell responses, and silk fibroin matrices. [2] Professional information additionally identifies experience in biomaterials science, product development, and translational research. [1]

Research Contributions

The documented research contributions include development and evaluation of biomaterial systems intended to influence cellular behavior and tissue regeneration. Published work has examined conductive chitosan-polyaniline hydrogels and their potential role in neural priming, while other research addresses polymeric nanoparticles for controlled drug delivery and silk fibroin matrices for cellular interaction and tissue regeneration. [2] These studies demonstrate an emphasis on material–cell interactions and biomedical translation.

Publications

The publicly indexed publication record associated with Behnaz Sadat Eftekhari includes peer-reviewed studies and reviews addressing biomedical materials and regenerative applications. Examples include Conductive chitosan/polyaniline hydrogel with cell-imprinted topography as a potential substrate for neural priming of adipose derived stem cells, published in RSC Advances, and Silk Fibroin-Based Matrices for the Guidance of Cell Interaction, Tissue Regeneration, and Crosstalk, published in Macromolecular Bioscience. [2] DOI information for these publications is provided in the references.

Research Impact

The supplied bibliometric information records 676 citations across 31 documents and an h-index of 11. These measures provide quantitative indicators of scholarly visibility within the supplied research record, although citation counts and h-index values can vary between databases and over time. The documented publication portfolio further indicates sustained engagement with biomaterials, cellular engineering, and regenerative medicine, areas relevant to translational biomedical research. [1]

Award Suitability

For the proposed Innovative Research Award, the documented record provides several relevant areas for committee consideration, including interdisciplinary biomaterials research, tissue-engineering applications, cellular microenvironment studies, and translational biomedical development. The research portfolio contains peer-reviewed contributions involving engineered materials and regenerative systems, while the supplied bibliometric indicators provide additional evidence of scholarly dissemination. Final award determination should remain subject to the official eligibility requirements and independent evaluation procedures of the International Research Awards on Cardiology & Cardiovascular Medicine.

Conclusion

Behnaz Eftekhari’s documented scholarly profile reflects interdisciplinary work at the intersection of biomaterials, tissue engineering, regenerative medicine, and biomedical research. Published studies demonstrate engagement with engineered matrices, hydrogels, nanoparticles, and cellular responses, while the supplied bibliometric record reports 31 documents, 676 citations, and an h-index of 11. Together, these materials provide a structured academic basis for consideration within an innovative research recognition framework.

References

  1. Elsevier. (n.d.). Scopus author details: Behnaz Eftekhari, Author ID 57198443389. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=57198443389
  2. Review article (2026). Functionalization of graphene oxide and its applications in tissue engineering and regenerative medicine.
    https://doi.org/10.1016/j.bioadv.2025.214421
  3. World Health Organization. (2026 ). Cardiovascular diseases. World Health Organization.
    https://cardiology-conferences.pencis.com/

Brian Morris | Hypertension | Best Academic Researcher Award

Published on by Cardiology and Cardiovascular Medicine

Prof. Dr. Brian Morris | Hypertension | Best Academic Researcher Award

University Of Sydney | Australia

Professor Dr. Brian Morris is a highly respected biomedical scientist and Professor Emeritus at the School of Medical Sciences, University of Sydney, acclaimed for his groundbreaking research in molecular medical sciences, hypertension, and public health. Throughout his distinguished career, he has made substantial contributions to understanding the genetic and molecular foundations of cardiovascular disease and ageing. He has held several prominent academic positions, including Professor of Molecular Medical Sciences and Senior Lecturer in Physiology, and has provided influential leadership in organizing international scientific conferences, such as the first global meeting on the molecular genetics of hypertension. Professor Morris has also served on major national and international research committees, editorial boards, and review panels, and is recognized as an exceptional mentor whose students have gone on to achieve senior positions in academia and industry worldwide. His numerous honors and fellowships from prestigious organizations reflect his exceptional contributions to science and education. With a prolific publication record of 404 documents, his research has received 11,835 citations from 8,579 documents, achieving an h-index of 56. His studies, published in leading journals including Circulation, Nature Genetics, PNAS, and Hypertension, have influenced scientific thought globally. His pioneering patent for the first use of PCR in viral detection further underscores his lasting impact on molecular diagnostics. Through his scientific innovation, academic leadership, and lifelong dedication to advancing knowledge, Professor Morris has made enduring contributions to cardiovascular and molecular health research worldwide.

Profiles: Scopus | Orcid

Featured Publications

Sarman, G., Cox, G., & Morris, B. J. (2025). Critique of “The impact of foot reflexology on postoperative pain and fear in children following circumcision: A randomized controlled trial.” Journal of Pediatric Urology.

Cox, G., & Morris, B. J. (2025). Comments on Fendereski et al., Comparing penile problems in circumcised vs. uncircumcised boys: Insights from a large commercial claims database with a focus on provider type performing circumcision. Journal of Pediatric Surgery.

Chen, R., Donlon, T. A., Morris, B. J., Allsopp, R. C., Willcox, B. J., & Masaki, K. H. (2024). Association of alcohol with lung cancer risk in men with different growth hormone receptor genotypes. Lung Cancer.

Chen, R., Morris, B. J., Donlon, T. A., Nakagawa, K., Allsopp, R. C., Willcox, B. J., Masaki, K. H., & Lipsitz, L. A. (2024). FOXO3 longevity genotype mitigates risk posed by hypertension on incident coronary artery disease in middle-aged men: Kuakini Honolulu Heart Program. The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences.

Morris, B. J., & Banerjee, J. (2024). Comment on ‘Changing relationships between HIV prevalence and circumcision in Lesotho’, and ‘Age-incidence and prevalence of HIV among intact and circumcised men: an analysis of PHIA surveys in Southern Africa’. Journal of Biosocial Science.

Morris, B. J., & Klausner, J. D. (2024). Detrimental to public health: Royal Australasian College of Physicians’ recent policy on infant circumcision. Pediatric Research.

Tao Chen | Cardiovascular Mortality | Best Researcher Award

Published on by Cardiology and Cardiovascular Medicine

Dr. Tao Chen | Cardiovascular Mortality | Best Researcher Award

Fujian Medical University | China 

Tao Chen is a distinguished medical professional and researcher in the field of endocrinology and metabolism, currently serving as an Associate Chief Physician at the Affiliated Longyan First Hospital of Fujian Medical University and as a postgraduate tutor at Fujian Medical University. With extensive clinical and academic experience, he has played a vital role in medical education, scientific research, and the advancement of endocrine medicine. His primary research interests encompass diabetes, insulin resistance, metabolic disorders, osteoporosis, and the role of vitamin D in neuropathy. Tao Chen has published five scholarly papers focusing on topics such as glucose regulation, serum irisin levels and their relationship with insulin sensitivity, the effects of exercise on metabolic indicators, and vitamin D3-related complications in type 2 diabetes. His publications have collectively received 25 citations across 5 documents, and he holds an h-index of 3, reflecting his consistent contribution to clinical and academic research. Beyond research, he is actively involved in multiple professional organizations, serving as a council and committee member in various endocrinology and diabetes societies. He is also the Vice Chairman of the Osteoporosis and Bone Mineral Salt Disease Branch of the Longyan Medical Association and serves as a food and drug safety expert for the Longyan Municipal People’s Government. Through his ongoing leadership, research, and mentorship, Tao Chen continues to make meaningful contributions to endocrinology and medical science.

Profiles: Scopus | Orcid

Featured Publications

Lai, X., & Chen, T. (2024). Association of serum uric acid to high-density lipoprotein cholesterol ratio with all-cause and cardiovascular mortality in patients with diabetes or prediabetes: A prospective cohort study. Frontiers in Endocrinology.

Lai, X., & Chen, T. (2024). Association between the triglyceride–glucose index and serum soluble Klotho in middle-aged and older adults from NHANES 2007–2016. Scientific Reports.

Chen, T., Xing, X., Huang, L., Tu, M., Lai, X., Wen, S., Cai, J., Lin, S., Zheng, Y., Lin, Y., et al. (2023). Efficacy and safety of high-dose intramuscular vitamin D₂ injection in type 2 diabetes mellitus with distal symmetric polyneuropathy combined with vitamin D insufficiency: Study protocol for a multicenter, randomized, double-blinded, and placebo-controlled trial. Frontiers in Endocrinology.

Chen, T. (2022). Type 2 diabetes mellitus complicated with atherosclerotic cardiovascular disease patient treated with semaglutide: A case report. Chinese Journal of Diabetes.